Cross allergic reactions between soya-bean & peanut. Stop infusion if any abnormal sign in electrolytes occurs. Interrupt infusion if sign or symptom of anaphylactic reaction (eg, fever, shivering, rash or dyspnea) occurs. Not to be given simultaneously w/ blood in the same infusion set. Not to exceed 4 mmol/L serum triglyceride conc during infusion. Fat overload syndrome w/ overdose. Impaired lipid metabolism in patients w/ renal failure, DM, pancreatitis, impaired liver function, hypothyroidism & sepsis. Lactic acidosis, insufficient cellular O
2 supply & increased serum osmolarity. Increased risk of infection. Increased urinary excretion of trace elements, particularly Cu & Zn. Patients w/ tendency towards electrolyte retention. Malnourished; hyperglycaemic patients. Monitor capacity to eliminate fat by checking triglyceride levels; serum glucose, electrolytes & osmolarity, fluid balance, acid-base status & liver enzyme tests; blood cell count & coagulation; serum levels. Correct electrolyte & fluid balance disturbances prior to infusion. Control phosphate & K intake in patients w/ renal insufficiency. May interfere w/ lab measurements eg, bilirubin, LDH, O
2 saturation, Hb. Not suitable for use in newborns or infants <2 yr.
SmofKabiven Consider intradialytic parenteral nutrition as recommended by international guidelines in adult malnourished hemodialysis patients.
SmofKabiven Peripheral Evaluate daily for local signs of thrombophlebitis. Childn 2-11 yr.